Transcat (NASDAQ:TRNS) Stock Rating Raised to “Strong-Buy” at Zacks Research

Zacks Research upgraded shares of Transcat (NASDAQ:TRNS) from a hold rating to a strong-buy rating in a research report released on Thursday,Zacks reports.

A number of other equities research analysts also recently commented on TRNS. Weiss Ratings reiterated a “sell (d+)” rating on shares of Transcat in a report on Tuesday, August 25th. CJS Securities started coverage on Transcat in a report on Tuesday, October 27th. They set an “outperform” rating and a $115.00 target price on the stock. Oppenheimer upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 target price on the stock in a report on Wednesday. Finally, Northland Securities upgraded Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $108.33.

Transcat Trading Up 1.1%

TRNS stock traded up $1.13 during midday trading on Thursday, reaching $101.51. The company’s stock had a trading volume of 169,759 shares, compared to its average volume of 135,380. The business’s 50-day simple moving average is $86.94 and its 200-day simple moving average is $82.43. The company has a quick ratio of 2.11, a current ratio of 2.49 and a debt-to-equity ratio of 0.36. Transcat has a 52 week low of $50.23 and a 52 week high of $110.47. The stock has a market cap of $953.18 million, a PE ratio of 211.48 and a beta of 0.61.

Transcat (NASDAQ:TRNS) last issued its earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.45 by $0.19. The company had revenue of $97.09 million during the quarter, compared to analysts’ expectations of $92.46 million. Transcat had a net margin of 0.99% and a return on equity of 5.56%. As a group, sell-side analysts expect that Transcat will post 2.06 EPS for the current year.

Insider Activity at Transcat

In other Transcat news, CEO Jaime A. Irick acquired 2,275 shares of the company’s stock in a transaction that occurred on Thursday, November 5th. The shares were acquired at an average price of $101.26 per share, with a total value of $230,366.50. Following the purchase, the chief executive officer owned 2,275 shares of the company’s stock, valued at $230,366.50. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.80% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TRNS. Wellington Management Group LLP acquired a new stake in shares of Transcat during the second quarter worth about $29,409,000. Bank of America Corp DE bought a new position in shares of Transcat during the 2nd quarter valued at about $2,386,000. Summit Creek Advisors LLC bought a new position in shares of Transcat during the 2nd quarter valued at about $4,357,000. Bank of New York Mellon Corp bought a new position in shares of Transcat during the 2nd quarter valued at about $2,742,000. Finally, Punch & Associates Investment Management Inc. acquired a new position in shares of Transcat in the 2nd quarter valued at approximately $7,430,000. 98.34% of the stock is owned by institutional investors and hedge funds.

Key Transcat News

Here are the key news stories impacting Transcat this week:

• Positive Sentiment: Zacks upgraded Transcat to Rank #1 (Strong Buy), citing improving earnings prospects, and included TRNS on its Strong Buy momentum-stock list. Zacks Strong Buy upgrade
• Positive Sentiment: Northland Securities raised its EPS forecasts across 2027–2031, including lifting its FY2027 estimate to $2.00 from $1.71 and its FY2031 estimate to $3.69 from $3.53. The revisions suggest stronger expected earnings growth. Northland estimate revisions
• Positive Sentiment: Oppenheimer raised its rating on Transcat to Outperform, adding to the favorable analyst sentiment. Oppenheimer rating upgrade
• Positive Sentiment: Recent coverage linked TRNS reaching a 52-week high to an earnings beat and improved outlook. The supplied background also reports quarterly EPS of $0.64 versus a $0.45 consensus estimate, with revenue above forecasts. Transcat 52-week high following earnings beat
• Neutral Sentiment: Northland maintained an Outperform rating but set a $95 price target, below the $101.32 share price cited in the background; this may temper the impact of its higher earnings forecasts. Northland rating and target

About Transcat

Transcat, Inc (NASDAQ: TRNS) provides calibration, compliance, and measurement services for organizations that rely on accurate test and measurement equipment. The company supports customers in regulated industries, including life sciences, aerospace and defense, energy, manufacturing, and other industrial markets.

Its service offerings include laboratory and onsite calibration, repair, validation, and asset-management services. Transcat calibrates a broad range of equipment used to measure temperature, pressure, electrical and electronic properties, radio frequency signals, dimensional characteristics, and other technical parameters.